About

Privè Advanced Facial Aesthetics is expanding its medical faculty and invites expressions of interest from NHS Consultant Dermatologists, Plastic Surgeons, and other Consultant-grade doctors with an interest in advanced aesthetic medicine.Applicants should have completed, or be undertaking, a Level 7 Diploma in Clinical Aesthetic Injectable Treatments with a JCCP-approved provider, or hold equivalent postgraduate aesthetic training and experience.Clinical Governance and StandardsPrivè operates within a robust governance framework and is:• Save Face accredited (Platinum)• JCCP approved• A member of the Cosmetic Redress Scheme• CQC registration pendingAll treatments are delivered within clearly defined clinical protocols, informed consent processes, and evidence-based practice standards.Centre of Excellence PartnershipIn January 2026, Privè entered a formal partnership with The Glow Group, the UK & Eire distributor for Toskani Med / Toskani, an established international pharmaceutical skincare manufacturer, becoming the first UK Toskani Med Centre of Excellence. This partnership provides access to the full professional and homecare Toskani Med and Toskani portfolio.Regenerative and Injectable TherapiesPrivè is the first UK clinic to clinically integrate Lumicen — Synergistic Regeneration with PDRN (3%), a professional regenerative line centred on polydeoxyribonucleotide (PDRN). PDRN has been studied for its role in:• Cellular repair and tissue regeneration• Collagen synthesis• Angiogenesis and dermal hydrationThe Lumicen professional range utilises a 3% high-purity PDRN concentration, currently regarded as the highest potency available commercially. The Lumicen Boost Serum has been shortlisted for the 2026 Aesthetics Awards (Innovative Product category).